Pfizer’s megablockbuster-to-be COVID pill Paxlovid scores FDA nod esagonowsky Wed, 12/22/2021 – 13:12

Biogen, Eisai face down another Aduhelm refusal—this time from Japanese regulators aliu Wed, 12/22/2021 – 09:18

Particulate problem prompts hold on 10 Gilead studies of HIV hopeful lenacapavir fkansteiner Wed, 12/22/2021 – 09:15

Despite myriad precautionary measures, virus-contaminated aerosols still pose a serious problem indoors. An invisible protective wall of UV-C […]

Research team from Chemnitz University of Technology, IFW Dresden and Max Planck Institute CBG presents a completely new […]

Calls for booster vaccinations in order to combat the rising cases brought about by winter and the recent […]

With authorisation, Pfizer’s oral antiviral candidate Paxlovid is an investigational SARS-CoV-2 protease inhibitor could be prescribed at the […]

Updated Date: Tue, 14 Dec 2021 00:00:00 EST

Updated Date: Tue, 14 Dec 2021 00:00:00 EST

Updated Date: Tue, 14 Dec 2021 00:00:00 EST